One Arm or Two? Concurrent administration of meningcoccal C conjugate and hepatitis B vaccines in pre-teens

Canadian Journal of Public Health

Volumn 99, Issue 1, 2008, Pages 52-56

  Pielak, Karen L ^a   McIntyre, Cheryl C ^a   Remple, Valencia P ^a   Buxton, Jane A ^a   Skowronski, Danuta M ^a  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Hepatitis B vaccine; Meningococcal vaccine; Vaccines administration

Indexed keywords

EID: 38949191289     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403741     Document Type: Article

References (16)

1. Halperin SA, McDonald J, Samson L, Danzig L, Santos G, Izu A, et al. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: A randomized double-blind study. Clin Invest Med 2002;25 (6):243-51.
2. Lakshman R, Jones I, Walker D, McMurtrie K, Shaw L, Race G, et al. Safety of a new conjugate meningococcal C vaccine in infants. Arch Dis Child 2001;85(5):391-97.
3. Ruggeberg J, Heath PT. Safety and efficacy of meningococcal group C conjugate vaccines. Expert Opin Drug Saf 2003;2(1):7-l9.
4. Bramley JC, Hall T, Finn A, Buttery RB, Elliman D, Lockhart S, et al. Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age. Vaccine 2001;19(20-22): 2924-31.
5. MacLennan JM, Shackley F, Heath PT, Deeks JJ, Flamank C, Herbert M, et al. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. JAMA 2000;283(21):2795-801.
6. Niu MT, Davis DM, Ellenberg S. Recombinant hepatitis B vaccination of neonates and infants: Emerging safety data from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 1996;15(9):771-76.
7. Pichichero ME, Blatter MM, Reisinger KS, Harrison CJ, Johnson CE, Steinhoff MC, et al. Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination. Pediatr Infect Dis J 2002;21(9):854-59.
8. British Columbia Centre for Disease Control. Section IV - Vaccine Administration. In: British Columbia Centre for Disease Control Communicable Disease Control Manual Chapter Two - Immunization. Vancouver, BC: British Columbia Centre for Disease Control, 2002;1-16.
9. Skowronski DM, Remple VP, Macnabb J, Pielak K, Parrick DM, Halperin SA, Scheifele D. Injection site reactions to booster doses of acellular pertussis vaccine: Rate, severity and anticipated impact. Pediatrics 2003; 112(6 Pt 1):e453.
10. Merck Frosst Canada & Co. Product Monograph: Recombivax HB®. Kirkland, QC. Author, 2002.
11. Shire Biologics. Product Monograph: Neis Vac-C Vaccine. Laval, QC: Author, 2004.
12. Gil Y, Meredith G, Chan YH, Goh CL. Do ethnicity and gender have an impact on pain threshold in minor dermatologic procedures? A study on thermal pain perception thresholds in Asian ethnic groups. Skin Research and Tecbnology 2004;10:38-42.
13. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology 1996;47:52-59.
14. Nelson DV, Novy DM, Averill PM, Berry LA. Ethnic comparability of the MMPI in pain patients. J Clin Psychol 1996;52:485-97.
15. Faucett J, Gordon N, Levine J. Differences in postoperative pain severity among four ethnic groups. J Pain Symptom Management 1994;9:383-89.
16. Rosmus C, Johnston CC, Chan-Yip A, Yang F. Pain response in Chinese and non-Chinese Canadian infants: Is there a difference? Soc Sci Med 2000;51:175-84.